A detailed history of Crescent Grove Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 8,315 shares of MRK stock, worth $824,681. This represents 0.1% of its overall portfolio holdings.

Number of Shares
8,315
Previous 8,794 5.45%
Holding current value
$824,681
Previous $1.09 Million 13.24%
% of portfolio
0.1%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$111.15 - $128.97 $53,240 - $61,776
-479 Reduced 5.45%
8,315 $944,000
Q2 2024

Jul 22, 2024

SELL
$123.8 - $132.96 $756,789 - $812,784
-6,113 Reduced 41.01%
8,794 $1.09 Million
Q1 2024

Apr 29, 2024

BUY
$113.24 - $131.95 $339 - $395
3 Added 0.02%
14,907 $1.97 Million
Q4 2023

Jan 30, 2024

BUY
$100.18 - $109.02 $200 - $218
2 Added 0.01%
14,904 $1.62 Million
Q3 2023

Oct 25, 2023

BUY
$102.95 - $114.33 $12,456 - $13,833
121 Added 0.82%
14,902 $1.53 Million
Q2 2023

Jul 13, 2023

SELL
$108.61 - $118.38 $246,761 - $268,959
-2,272 Reduced 13.32%
14,781 $1.71 Million
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $251,482 - $280,602
-2,443 Reduced 12.53%
17,053 $1.81 Million
Q4 2022

Jan 12, 2023

SELL
$87.44 - $112.11 $11,454 - $14,686
-131 Reduced 0.67%
19,496 $0
Q3 2022

Nov 08, 2022

BUY
$84.53 - $94.96 $144,377 - $162,191
1,708 Added 9.53%
19,627 $1.7 Million
Q2 2022

Jul 20, 2022

SELL
$83.49 - $94.64 $185,097 - $209,816
-2,217 Reduced 11.01%
17,919 $1.65 Million
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $215,163 - $241,184
2,927 Added 17.01%
20,136 $1.67 Million
Q4 2021

Jan 24, 2022

BUY
$72.28 - $90.54 $31,947 - $40,018
442 Added 2.64%
17,209 $1.33 Million
Q3 2021

Oct 26, 2021

BUY
$71.68 - $78.83 $3,512 - $3,862
49 Added 0.29%
16,767 $1.27 Million
Q2 2021

Jul 26, 2021

BUY
$70.31 - $77.77 $104,761 - $115,877
1,490 Added 9.78%
16,718 $1.31 Million
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $69,548 - $81,921
1,010 Added 7.1%
15,228 $1.18 Million
Q4 2020

Feb 01, 2021

BUY
$71.77 - $79.65 $20,597 - $22,859
287 Added 2.06%
14,218 $1.17 Million
Q3 2020

Nov 06, 2020

BUY
$73.18 - $82.95 $219 - $248
3 Added 0.02%
13,931 $1.16 Million
Q2 2020

Aug 03, 2020

BUY
$70.42 - $80.13 $2,394 - $2,724
34 Added 0.24%
13,928 $1.09 Million
Q1 2020

Apr 27, 2020

SELL
$63.36 - $87.82 $3,991 - $5,532
-63 Reduced 0.45%
13,894 $1.08 Million
Q4 2019

Feb 03, 2020

BUY
$77.58 - $87.54 $232 - $262
3 Added 0.02%
13,957 $1.28 Million
Q3 2019

Oct 31, 2019

SELL
$76.08 - $82.93 $8,292 - $9,039
-109 Reduced 0.78%
13,954 $1.18 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $21,859 - $25,537
313 Added 2.28%
14,063 $1.19 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $4,731 - $5,396
68 Added 0.5%
13,750 $1.15 Million
Q4 2018

Jan 29, 2019

BUY
$65.24 - $75.71 $5,023 - $5,829
77 Added 0.57%
13,682 $1.05 Million
Q3 2018

Nov 05, 2018

BUY
$57.69 - $67.84 $173 - $203
3 Added 0.02%
13,605 $972,000
Q2 2018

Jul 16, 2018

BUY
$50.83 - $59.72 $152 - $179
3 Added 0.02%
13,602 $832,000
Q1 2018

May 03, 2018

BUY
$50.96 - $59.23 $27,467 - $31,924
539 Added 4.13%
13,599 $747,000
Q4 2017

Feb 06, 2018

SELL
$51.62 - $61.64 $6,400 - $7,643
-124 Reduced 0.94%
13,060 $741,000
Q3 2017

Nov 06, 2017

BUY
$58.67 - $63.13 $773,505 - $832,305
13,184
13,184 $850,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Crescent Grove Advisors, LLC Portfolio

Follow Crescent Grove Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crescent Grove Advisors, LLC with notifications on news.